menu
    • menu

    Company profile for Aptamer Group

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aptamer Group is a world-leading provider of Optimer™ reagents for use in research, diagnostics and therapeutics. The Company strives to deliver transformational solutions, that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology.At Aptamer Group, we have successfully delivered projects for global pharma companies, diagnostic development companies, and r...
    Aptamer Group is a world-leading provider of Optimer™ reagents for use in research, diagnostics and therapeutics. The Company strives to deliver transformational solutions, that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology.At Aptamer Group, we have successfully delivered projects for global pharma companies, diagnostic development companies, and research institutes covering a range of targets and applications with the objective of establishing royalty-bearing licenses.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aptamer Groupunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Innovation Way, York, England YO10 5NY
    Telephone
    Telephone
    +44 (0) 19045677
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aptamergroup.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/the-aptamer-group/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AptamerGroup

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptamer Expands Multi-Target Optimer Development Program Pact
    Aptamer Expands Multi-Target Optimer Development Program Pact

    05 Nov 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aptamer-expands-multi-target-optimer-development-program-pact/

    CONTRACTPHARMA
    05 Nov 2025
    Share Share
    Aptamer Inks Development Agreement With 3 Pharma Giant Company
    Aptamer Inks Development Agreement With 3 Pharma Giant Company

    08 Oct 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aptamer-enters-development-agreement-with-top-3-global-pharma-company/

    CONTRACTPHARMA
    08 Oct 2025
    Share Share
    Aptamer Teams Up with Invizius for Advanced Complement System
    Aptamer Teams Up with Invizius for Advanced Complement System

    03 Sep 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aptamer-group-partners-with-invizius-to-develop-next-gen-complement-system-therapies/

    CONTRACTPHARMA
    03 Sep 2025
    Share Share
    Aptamer Group Inks New Development Deals, Licensing Agreement
    Aptamer Group Inks New Development Deals, Licensing Agreement

    15 May 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/aptamer-group-inks-new-development-deals-licensing-agreement/

    CONTRACTPHARMA
    15 May 2025
    Share Share
    Nucleic Acid Aptamer Pharmacokinetics Extended in Joint Research
    Nucleic Acid Aptamer Pharmacokinetics Extended in Joint Research

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/successful-extension-of-nucleic-acid-aptamer-pharmacokinetics-in-joint-research-by-ajinomoto-co-inc-and-ribomic-inc-302447922.html

    PR NEWSWIRE
    06 May 2025
    Share Share
    HKBU Aptamer for X-link Hypophosphatemia Receive Orphan Designation
    HKBU Aptamer for X-link Hypophosphatemia Receive Orphan Designation

    23 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aptamer-developed-by-hkbu-for-treating-rare-bone-disease-x-linked-hypophosphatemia-receives-orphan-drug-designation-and-rare-pediatric-disease-designation-by-us-fda-302338168.html

    PR NEWSWIRE
    23 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search